KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Return on Assets (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Return on Assets for 14 consecutive years, with 0.03% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 8.0% to 0.03% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.03% through Dec 2025, down 8.0% year-over-year, with the annual reading at 0.03% for FY2025, 8.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.03% at Supernus Pharmaceuticals, down from 0.01% in the prior quarter.
  • The five-year high for Return on Assets was 0.07% in Q1 2021, with the low at 0.03% in Q4 2025.
  • Average Return on Assets over 5 years is 0.03%, with a median of 0.03% recorded in 2021.
  • Peak annual rise in Return on Assets hit 6bps in 2025, while the deepest fall reached -8bps in 2025.
  • Over 5 years, Return on Assets stood at 0.03% in 2021, then increased by 9bps to 0.04% in 2022, then tumbled by -97bps to 0.0% in 2023, then skyrocketed by 5352bps to 0.05% in 2024, then crashed by -149bps to 0.03% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.03%, 0.01%, and 0.05% for Q4 2025, Q3 2025, and Q2 2025 respectively.